PDS Biotechnology Corporation — Quarterly Financial Data (NASDAQ:PDSB) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Новости

PDS Biotech modifica lo studio di Fase 3 per includere percorso di approvazione accelerata

PDS Biotech amends Phase 3 trial to add accelerated approval path

PDS Biotech riporta sopravvivenza libera da progressione di 9,6 mesi in studio sul cancro alla prostata

PDS Biotech reports 9.6-month progression-free survival in prostate cancer study

PDS Biotech ottiene brevetto per l’immunoterapia anticancro PDS0101

PDS Biotech secures patent for cancer immunotherapy PDS0101

Il titolo PDS Biotech vola dopo l’incontro con la FDA per l’approvazione accelerata

PDS Biotech stock soars after FDA meeting provides accelerated approval path

PDS Biotech presenta protocollo modificato per trial di fase 3 contro il cancro

PDS Biotech submits amended protocol for phase 3 cancer trial

PDS Biotech secures new patent for cancer immunotherapy in Japan

PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why